Crystal S Denlinger

7PUBLICATIONS
24CO-AUTHORS
Molecular targetsExercise physiologyPacific Peoples biomedical and clinical scienceAerospace materialsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 21, 2022
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Kelsey A Klute, Michael Rothe, Elizabeth Garrett-Mayer

|May 31, 2022
The effects of exercise and diet on sex steroids in breast cancer survivors.

Justin C Brown, Kathleen Sturgeon, David B Sarwer

|Sep 03, 2021
Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience.

Arjun Gupta, Omar Khalid, Cassadie Moravek

|Jul 12, 2021
Phase 1 dose escalation study of seribantumab (MM-121), an anti-HER3 monoclonal antibody, in patients with advanced solid tumors.

Crystal S Denlinger, Vicki L Keedy, Victor Moyo

|Sep 05, 2020
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors.

Ani S Balmanoukian, Jeffrey R Infante, Raid Aljumaily

|Jul 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer.

Efrat Dotan, Dana B Cardin, Heinz-Josef Lenz

Pageof 2

Frequent Collaborators

2 joint publications

Keun-Wook Lee

1 joint publications

Geoffrey Y Ku

1 joint publications

Dana B Cardin

1 joint publications

Aung Naing